Parainfluenza virus type 3 induced alterations in tachykinin NK1 receptors, substance P levels and respiratory functions in guinea pig airways.
We have investigated the effects of parainfluenza virus type 3 (PI-3) on sensory neuropeptide levels, tachykinin receptors and their functions in guinea pig airways during the course of respiratory viral infection. PI-3 infected guinea pigs were hyperresponsive to methacholine and substance P aerosols as determined by earlier onset of dyspnea in these animals as compared with control on post-inoculation day (PID) 7 but not 19. In addition, plasma protein extravasation produced in response to the tachykinin was increased in infected airways during the first week post inoculation. Infected guinea pig trachea did not respond any differently to methacholine when smooth muscle contraction and [3H]inositol phosphate accumulation were measured although the magnitude of substance P effects using in vitro tests was significantly greater than control on post-inoculation day 7 but not 19. Trachea from PI-3 infected animals were characterized by reductions in substance P-like immunoreactivity, tachykinin NK1 receptor number and agonist affinity during the first post-inoculation week. Substance P levels or tachykinin NK1 receptor numbers or affinity were not altered in trachea of guinea pigs 4 days after treatment with lipopolysaccharide. These data suggest substance P release occurs during critical periods of respiratory viral infection which are temporally correlated with airway hyperresponsiveness. Despite apparent down-regulation of tachykinin NK1 receptors, substance P-mediated functions remained enhanced suggesting some alterations in post-receptor mechanisms.
Kudlacz
E M
EM
Marion Merrell Dow Research Institute, Cincinnati, OH 45215.
Shatzer
S A
SA
Farrell
A M
AM
Baugh
L E
LE
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D002199:Capillary Permeability / Q000502:physiology; D004926:Escherichia coli; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D016210:Methacholine Chloride / Q000494:pharmacology; D009130:Muscle, Smooth / Q000502:physiology; D009475:Neurons, Afferent / Q000378:metabolism / Q000502:physiology; D009479:Neuropeptides / Q000378:metabolism; D010224:Parainfluenza Virus 3, Human; D018184:Paramyxoviridae Infections / Q000378:metabolism / Q000503:physiopathology*; D011869:Radioligand Assay; D018040:Receptors, Neurokinin-1 / Q000378:metabolism*; D015656:Respiratory Mechanics / Q000502:physiology*; D013373:Substance P / Q000378:metabolism* / Q000494:pharmacology; D013569:Synapses / Q000502:physiology; D014132:Trachea / Q000294:innervation / Q000378:metabolism / Q000503:physiopathology*
D001798:Blood Proteins; D007295:Inositol Phosphates; D008070:Lipopolysaccharides; D009479:Neuropeptides; D018040:Receptors, Neurokinin-1; D016210:Methacholine Chloride; D013373:Substance P